Clinical Trials on Alzheimer's Disease

The Clinical Trials on Alzheimer's Disease conference (CTAD) is a meeting focused entirely on Alzheimer’s Disease Therapeutic Trials with key leaders in Alzheimer Disease research from Industry and Academia getting together and forming partnerships with the objective of speeding the development of effective treatments to fight the disease. 

This conference is expecting 2,200 key decision makers in the field of AD clinical trials; Industry leaders from major pharmaceutical companies involved in AD therapeutic trials; Internationally recognized researchers; KOL’s, etc.